skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

Refine Results

Clear All

Specialism

Show More

Resources

Show More

Show More

Products

Show More

Show More

991 Total results for product and free and sample content found

Pink Sheet

Express Scripts Pushing Manufacturers To Lower List Prices By Offering Cheaper Brand Alternatives

By Cathy Kelly 16 Jul 2018

Companies should introduce same drug under new NDC at lower list price to overcome difficulties of reducing list prices on existing brands, PBM says.

Topic Policy and regulation

Pink Sheet

Long-Awaited Brexit White Paper Lays Out UK's Plans For Medicines Regulation

By Francesca Bruce 16 Jul 2018

The UK government has finally published its white paper on the UK’s future relationship with the EU following Brexit, to the relief of the pharmaceutical industry.

Topic Brexit

Pharmaprojects

Microbiome Modulators for Gastrointestinal Disorders In 2018: Market Overview & The Current Phase I Candidates

13 Jul 2018

The discovery and deep investigation of the microbiome has been one of the most significant recent biomedical advances. Extensive research suggests that dysbiosis of the gut microbiome plays a significant role in multiple gastrointestinal (GI) disorders such as; Crohn’s disease, ulcerative colitis, and irritable bowel syndrome (IBS).

Pharmaprojects

2018 R&D Review: 5 Key Takeaways

13 Jul 2018

Welcome to Pharmaprojects’ roundup of key trends in pharmaceutical R&D in 2018, focusing on five key takeaways from our full annual report

Scrip

Authorities Find Accounting Violation By Samsung BioLogics, Prosecutors To Probe

By Jung Won Shin 13 Jul 2018

South Korean financial authorities conclude Samsung BioLogics violated accounting standards by omitting certain information on its joint venture agreement with Biogen from public disclosures, and have ordered further investigation of a corporate governance decision on the handling in accounts of the JV, Samsung Bioepis. The latest ruling in the prolonged affair could hurt the credibility and business of Samsung BioLogics going forward, although the firm maintains it has done nothing improper. 

Topic Policy and regulation

Scrip

Mylan's Fulphila Sets Up The US Market For The Next Biosimilar Showdown

By Jessica Merrill 13 Jul 2018

Mylan has priced its biosimilar version of pegfilgrastim at a 33% discount to Amgen's WAC for Neulasta, steeper than the 15% discount Pfizer initially offered for Inflectra. The commercial outcome for Fulphila could set the tone for future US biosimilars, which have yet to take off.

Topic Biosimilars Business strategies

Primal Pictures

Primal Pictures partners with Insight Learning Technology

13 Jul 2018

London – May 21, 2018 – Primal Pictures, part of Informa Pharma Intelligence, and pioneer of the world’s most medically-accurate and detailed three-dimensional model of human anatomy, announces today that it has partnered with Insight Learning Technology(ILT), a learning technology company applying cutting-edge research in cognitive science to achieve breakthroughs in computer-based learning.

Primal Pictures

Primal Pictures Partners with Physitrack to Create a Unique Patient Education Solution

12 Jul 2018

London, UK, June 22, 2018 – Today, Primal Pictures, pioneer of the world’s most medically-accurate and detailed 3D models of human anatomy, and Physitrack, the market-leading patient engagement and Telehealth solution provider, announce their partnership on a unique anatomically augmented home exercise and patient education feature.

In Vivo

Cancer Vaccines: Is There A Future Beyond Trial And Error?

By William Looney 12 Jul 2018

Strong foundational research in immunology and some promising early phase trial results have so far failed to expedite the validation of vaccines to treat cancer. In Vivo examines biopharma’s enduring optimism about the future of cancer vaccinology, including a closer look at one company’s platform to tackle the incurable malignancies that beset the mother of all organs: the human brain.

Topic Cancer Vaccines

Next steps

Getting a demo tailored to your needs is the best way to see how our solutions will help you gain an advantage.

Request live demo now:

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: